Remimazolam for Sedation During Upper Gastrointestinal Endoscopy in an Adolescent

Remimazolam is a short-acting benzodiazepine that has recently received approval from the US Food and Drug Administration (FDA) for procedural sedation in adults. Similar to other benzodiazepines such as midazolam, remimazolam has sedative, anxiolytic, and amnestic properties. Rapid metabolism by pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrett, Alexandrea, Flowers, Jessie, Ng, Vanessa, Tobias, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635772/
https://www.ncbi.nlm.nih.gov/pubmed/36407860
http://dx.doi.org/10.14740/jmc4013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635772/
https://www.ncbi.nlm.nih.gov/pubmed/36407860
http://dx.doi.org/10.14740/jmc4013

Ejemplares similares